Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

Subjects:

The global prevalence of gynecological diseases among women aged 15-49 years in 1990 and 2021, along with the trends and changes observed between these years. by Xiaofeng He (2618752)

Subjects:

Summary of the screened symptoms at baseline (t0) for completers (n = 160). by Anton Kurapov (11346019)

Subjects:

Summary of the program evaluation. by Anton Kurapov (11346019)

Subjects:

Changes in continuous sleep measures from pre (t1) to post (t2) intervention. by Anton Kurapov (11346019)

Subjects:

Sociodemographic information, participant flow, engagement, and compliance. by Anton Kurapov (11346019)

Subjects:

Changes in mental health symptoms after the sleep intervention (n = 160 completers). by Anton Kurapov (11346019)

Subjects:

‘Sleep2Ukraine’ study design. by Anton Kurapov (11346019)

Subjects:

Density differences between pre- and post-measurements for program completers (N = 160). by Anton Kurapov (11346019)

Subjects:

related to Fig 3. (A) Live eggs induce AIM2 pyroptosome formation. Microscopy of AIM2-citrine macrophages stimulated with live eggs for 48 h. by Madhusoodhanan Suresh Kumar Meena Kumari (20896666)

Subjects:

Experimental process. by Yi Wang (32470)

Subjects:

SARA test results for different types of asphalt. by Yi Wang (32470)

Subjects:

SARA test results of different asphalt. by Yi Wang (32470)

Subjects:

Different asphalt modeling. by Yi Wang (32470)

Subjects:

Sociodemographic characteristics of stroke patients including lost to follow-up/missing data (n = 188). by Farayi Kaseke (19560197)

Subjects: